LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
Novartis’ New Head of Ophthalmology Lays Out Lofty Goals Days Before Xiidra Deal
VANCOUVER – Novartis is one of the world’s largest ophthalmic pharmaceutical companies, with $4.6 billion in assets as part of the Medicines division, yet some ...
A Dozen Takeaways from OIS@ASCRS 2019
Last week’s OIS@ASCRS 2019 saw a record number of registrants, and the 650 attendees were treated to a wealth of information from the presenting companies, ...
Protocol V, LEAVO Among Retina Highlights at ARVO 2019
VANCOUVER – Leave it to ARVO 2019 – the Association for Research in Vision and Ophthalmology – to keep attendees waiting until mid-evening to hear ...
OIS@ASCRS Features New Sessions, Companies
OIS@ASCRS 2019 will convene next Thursday, May 2, preceding the American Society of Cataract and Refractive Surgery annual meeting in San Diego. This year’s OIS@ASCRS ...
Takeaway from FDA Imaging Forum: Need for Consensus Standards for Optical Coherence Tomography
Continued advances in optical coherence tomography are generating excitement for more precise and earlier diagnosis of eye disease, but more research and industry agreement on ...
Will Dexycu’s Cost Inhibit Its Use?
Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island, recently performed the first cataract surgery in the country using Dexycu (EyePoint Pharmaceuticals), administered as a ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.